BiotechTube

Edoxaban + Apixaban + Rivaroxaban

Pre-clinicalCompleted
1 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Atrial Fibrillation

Conditions

Atrial Fibrillation

Trial Timeline

Feb 15, 2019 → Jul 9, 2021

NCT ID
NCT05262322

About Edoxaban + Apixaban + Rivaroxaban

Edoxaban + Apixaban + Rivaroxaban is a pre-clinical stage product being developed by Daiichi Sankyo for Atrial Fibrillation. The current trial status is completed. This product is registered under clinical trial identifier NCT05262322. Target conditions include Atrial Fibrillation.

What happened to similar drugs?

20 of 20 similar drugs in Atrial Fibrillation were approved

Approved (20) Terminated (4) Active (0)
✅OAC aloneDaiichi SankyoApproved
✅EdoxabanDaiichi SankyoApproved
✅Edoxaban + Aspirin and Clopidogrel + Aspirin and WarfarinDaiichi SankyoApproved
✅dapagliflozin + PlaceboAstraZenecaApproved
✅valsartanNovartisApproved
✅Apixaban + Parenteral heparin and/or oral Vitamin K antagonistPfizerApproved
✅Vitamin K antagonist + ApixabanPfizerApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT05262322Pre-clinicalCompleted

Competing Products

20 competing products in Atrial Fibrillation

See all competitors
ProductCompanyStageHype Score
EdoxabanDaiichi SankyoPre-clinical
26
Edoxaban + Clopidogrel + Prasugrel + Ticagrelor + Vitamin K antagonistDaiichi SankyoPhase 3
40
OAC aloneDaiichi SankyoApproved
43
Edoxaban + ASADaiichi SankyoPhase 3
32
DU-176b tablets + DU-176b tablets + Warfarin tabletsDaiichi SankyoPhase 2
35
Edoxaban + VKA-Based Regimen + VKA-Based Regimen + VKA-Based Regimen + VKA-Based RegimenDaiichi SankyoPhase 3
40
Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + warfarinDaiichi SankyoPhase 2
35
EdoxabanDaiichi SankyoPre-clinical
26
EdoxabanDaiichi SankyoApproved
43
Edoxaban + Warfarin + EnoxaparinDaiichi SankyoPhase 3
40
EdoxabanDaiichi SankyoPre-clinical
26
EdoxabanDaiichi SankyoPre-clinical
26
DU-176b 15mg + DU-176b 30mg + DU-176b 60mgDaiichi SankyoPhase 3
40
dabigatran, rivaroxaban, apixaban or edoxabanDaiichi SankyoPre-clinical
22
EdoxabanDaiichi SankyoPre-clinical
26
DU-176b tablets + Warfarin potassium tabletsDaiichi SankyoPhase 2
35
Edoxaban-based Regimen + VKA-based RegimenDaiichi SankyoPhase 3
40
EdoxabanDaiichi SankyoPre-clinical
26
Edoxaban + Aspirin and Clopidogrel + Aspirin and WarfarinDaiichi SankyoApproved
39
EdoxabanDaiichi SankyoPre-clinical
26